Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Expert Opinion on Pharmacotherapy|August 1, 2024
Cytokine release syndrome after CAR T-cell therapy for B-cell acute lymphoblastic leukemia in children and young adolescents: storms make trees take deeper rootsMagalie Tardif, Nida Usmani, Maja Krajinovic, et al.
Drug Design, Development and Therapy|December 7, 2018
CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemiaStephanie Vairy, Julia Lopes Garcia, Pierre Teira, et al.
Journal of Pediatric Hematology/Oncology|October 9, 2023
Gemtuzumab Ozogamicin Monotherapy Is a Well-tolerated Palliative Chemotherapy Option in Pediatric Multiply Relapsed Acute Myeloid Leukemia: A Multicenter Case Series and Review of the LiteratureSarah Blain, Noémie Payette, Henrique Bittencourt, et al.
Expert Opinion on Pharmacotherapy|June 14, 2017
Novel therapy for childhood acute lymphoblastic leukemiaRaoul Santiago, Stéphanie Vairy, Daniel Sinnett, et al.
Expert Opinion on Pharmacotherapy|May 20, 2021
Molecular-based and antibody-based targeted pharmacological approaches in childhood acute lymphoblastic leukemiaMagalie Tardif, Amalia Souza, Maja Krajinovic, et al.
Journal of the Pediatric Infectious Diseases Society|February 11, 2017
Posaconazole Plasma Monitoring in Immunocompromised ChildrenJessica McMahon, Yves Théorêt, Julie Autmizguine, et al.
Revista Portuguesa De Pneumologia|October 8, 2010
[Non-infectious pulmonary complications after the hematopoietic stem cell transplantation]Eliane Viana Mancuzo, Marina Augusto Neves, Henrique Bittencourt, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|October 19, 2017
A Retrospective Study on Infusion-Related Reactions to Rituximab in a Heterogeneous Pediatric PopulationClément Legeay, Henrique Bittencourt, Elie Haddad, et al.
Journal of Pediatric Hematology/Oncology|July 1, 2014
Calcineurin inhibitor-free graft-versus-host disease prophylaxis with sirolimus and mycophenolate mofetil in a second allogeneic stem cell transplantation for engraftment failure and rituximab-refractory Epstein-Barr virus-induced posttransplant lymphoproliferative diseaseFrancesco Ceppi, Michel Duval, Pierre Teira, et al.
Plos One|April 3, 2018
Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in childrenJoy Benadiba, Marc Ansari, Maja Krajinovic, et al.
Pageof 10